Sources: Sanofi’s Brandicourt looks at spinoff of animal health, selling supplement biz

Eric Palmer

New Sanofi CEO Olivier  has promised to unveil his 5-year strategic plan for the French drugmaker and he appears to be homing in on what to keep and what to let go. say that he is considering a of Sanofi's operation, while maybe unloading a business and a biosurgery unit that were picked up by his predecessors.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS